1h Free Analyst Time
The Parenteral Nutrition Market grew from USD 7.67 billion in 2023 to USD 8.33 billion in 2024. It is expected to continue growing at a CAGR of 8.66%, reaching USD 13.73 billion by 2030. Speak directly to the analyst to clarify any post sales queries you may have.
Parenteral Nutrition (PN) is defined as the medical administration of nutritional support intravenously, bypassing the digestive system, to patients who cannot consume or absorb nutrients via the gastrointestinal tract. The necessity of PN arises in cases of severe digestive disorders, trauma, surgeries, or chronic illnesses. It is predominantly applied in hospital settings, catering to a diverse range of patients from neonates to adults, who require life-sustaining nutrition without oral or enteral intake options. Major end-users include hospitals, clinics, and homecare settings, where PN is adapted for outpatient chronic care needs. Market growth is significantly influenced by the rising prevalence of chronic diseases, advancements in healthcare infrastructure, and increasing adoption of homecare nutrition. The growing aging population further necessitates tailored nutritional solutions like PN. Potential opportunities include developing formulations that provide tailored lipids, amino acids, and micronutrients, meeting specific patient requirements, and enhancing delivery systems for safety and efficacy. Emphasis on home-based PN can open new avenues for growth, especially with technological advancements in portable infusion systems. However, the market is challenged by high costs, complexities in admixture preparation, risk of infections, and stringent regulatory approvals affecting product reach and development pace. Moreover, awareness and expertise in administering PN remain uneven across regions, posing barriers in emerging markets. Innovation should focus on designing safer, easy-to-use delivery systems, enhancing the stability of emulsions, expanding patient education, and tele-health consultations to support homecare PN. The PN market is characterized by its high entry barriers due to stringent regulation and the need for specialized expertise. Yet, the growing comfort with personalized medical solutions and telemedicine offers fertile ground for research and development, particularly in optimizing patient nutrition through innovative delivery technologies and formulations.
Understanding Market Dynamics in the Parenteral Nutrition Market
The Parenteral Nutrition Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.- Market Drivers
- Prevalence of chronic diseases such as kidney diseases, liver diseases and cancer
- Increasing rate of geriatric population and malnourished individuals
- High natality and premature births around the globe
- Market Restraints
- Strict government rules regarding the approval of parenteral nutrition
- Market Opportunities
- Innovative parenteral and enteral nutrition therapy
- Technological developments in parenteral nutrition
- Market Challenges
- Associated complexities with parenteral nutrition
Exploring Porter’s Five Forces for the Parenteral Nutrition Market
Porter’s Five Forces framework further strengthens the insights of the Parenteral Nutrition Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.Applying PESTLE Analysis to the Parenteral Nutrition Market
External macro-environmental factors deeply influence the performance of the Parenteral Nutrition Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.Analyzing Market Share in the Parenteral Nutrition Market
The Parenteral Nutrition Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.Evaluating Vendor Success with the FPNV Positioning Matrix in the Parenteral Nutrition Market
The Parenteral Nutrition Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.Strategic Recommendations for Success in the Parenteral Nutrition Market
The Parenteral Nutrition Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.Key Company Profiles
The report delves into recent significant developments in the Parenteral Nutrition Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., ACULIFE HEALTHCARE PRIVATE LIMITED, ALBERT DAVID LIMITED by Kothari Group, Amanta Healthcare Ltd., AMINO GmbH, B. Braun Melsungen AG, Baxter International Inc., Claris Lifesciences Limited, Evonik Industries AG, Fresenius Kabi AG, Grifols S.A., Hamilton Bonaduz AG, ICU Medical, Inc., Otsuka Holdings Co., Ltd., Pfizer Inc., Sichuan Kelun Pharmaceutical Co., Ltd., and Well Pharma Medical Solutions LLC.Market Segmentation & Coverage
This research report categorizes the Parenteral Nutrition Market to forecast the revenues and analyze trends in each of the following sub-markets:- Nutrient Type
- Amino Acids
- Carbohydrates
- Electrolytes
- Lipids
- Multivitamin Formulations & Trace Elements
- Dosage Form
- Ampules
- Bags
- Bottles
- Vials
- End-User
- Clinics
- Hospitals
- Long-Term Care Providers
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report provides a detailed overview of the market, exploring several key areas:
- Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
- Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
- Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
- Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
- Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.
Additionally, the report addresses key questions to assist stakeholders in making informed decisions:
- What is the current size of the market, and how is it expected to grow?
- Which products, segments, and regions present the most attractive investment opportunities?
- What are the prevailing technology trends and regulatory factors influencing the market?
- How do top vendors rank regarding market share and competitive positioning?
- What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?
Table of Contents
1. Preface
2. Research Methodology
4. Market Overview
5. Market Insights
6. Parenteral Nutrition Market, by Nutrient Type
7. Parenteral Nutrition Market, by Dosage Form
8. Parenteral Nutrition Market, by End-User
9. Americas Parenteral Nutrition Market
10. Asia-Pacific Parenteral Nutrition Market
11. Europe, Middle East & Africa Parenteral Nutrition Market
12. Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
The leading players in the Parenteral Nutrition Market, which are profiled in this report, include:- AbbVie Inc.
- ACULIFE HEALTHCARE PRIVATE LIMITED
- ALBERT DAVID LIMITED by Kothari Group
- Amanta Healthcare Ltd.
- AMINO GmbH
- B. Braun Melsungen AG
- Baxter International Inc.
- Claris Lifesciences Limited
- Evonik Industries AG
- Fresenius Kabi AG
- Grifols S.A.
- Hamilton Bonaduz AG
- ICU Medical, Inc.
- Otsuka Holdings Co., Ltd.
- Pfizer Inc.
- Sichuan Kelun Pharmaceutical Co., Ltd.
- Well Pharma Medical Solutions LLC
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 186 |
| Published | October 2024 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 8.33 Billion |
| Forecasted Market Value ( USD | $ 13.73 Billion |
| Compound Annual Growth Rate | 8.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 18 |
